Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin Desensitization in Aspirin-exacerbated Respiratory Diseases
NCT01867281Phase 4Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2013
- Primary completion
- Jun 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin in Aspirin Exacerbated Respiratory Disease (AERD), sponsored by Tehran University of Medical Sciences. Started Jun 2013; status: completed.
02
Drugs
aspirin
03
Conditions
Aspirin Exacerbated Respiratory Disease (AERD)
Beyond the preview
Go deeper on NCT01867281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01867281.